Context: Researchers have identified a new class of antibiotics with the potential to tackle a drug-resistant bacterium, Acinetobacter baumannii.
Zosurabalpin: New Class of Antibiotic for Drug-Resistant Bacterium
- Zosurabalpin was found to be effective against CRAB (carbapenem-resistant Acinetobacter baumannii)-induced pneumonia and sepsis in mouse models.
- Trials: The antibiotic has been evaluated in two phase I clinical trials.
About Acinetobacter baumannii
- It is a bacterial pathogen primarily associated with hospital-acquired infections.
- It is commonly associated with aquatic environments and colonizes the skin as well as the respiratory and oropharynx secretions of infected individuals.
|
What is Antimicrobial Resistance (AMR)?
- Antimicrobial Drug Resistance or Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines.
- Impact: Infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death.
- Reason: AMR is a natural process that happens over time through genetic changes in pathogens.
To Read More: Antimicrobial Resistance (AMR)
News Source: The Hindu